» Articles » PMID: 10891488

Increased Energy Expenditure, Decreased Adiposity, and Tissue-specific Insulin Sensitivity in Protein-tyrosine Phosphatase 1B-deficient Mice

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2000 Jul 13
PMID 10891488
Citations 361
Authors
Affiliations
Soon will be listed here.
Abstract

Protein-tyrosine phosphatase 1B (PTP-1B) is a major protein-tyrosine phosphatase that has been implicated in the regulation of insulin action, as well as in other signal transduction pathways. To investigate the role of PTP-1B in vivo, we generated homozygotic PTP-1B-null mice by targeted gene disruption. PTP-1B-deficient mice have remarkably low adiposity and are protected from diet-induced obesity. Decreased adiposity is due to a marked reduction in fat cell mass without a decrease in adipocyte number. Leanness in PTP-1B-deficient mice is accompanied by increased basal metabolic rate and total energy expenditure, without marked alteration of uncoupling protein mRNA expression. In addition, insulin-stimulated whole-body glucose disposal is enhanced significantly in PTP-1B-deficient animals, as shown by hyperinsulinemic-euglycemic clamp studies. Remarkably, increased insulin sensitivity in PTP-1B-deficient mice is tissue specific, as insulin-stimulated glucose uptake is elevated in skeletal muscle, whereas adipose tissue is unaffected. Our results identify PTP-1B as a major regulator of energy balance, insulin sensitivity, and body fat stores in vivo.

Citing Articles

Pathogenetic therapeutic approaches for endocrine diseases based on antisense oligonucleotides and RNA-interference.

Golounina O, Minniakhmetov I, Salakhov R, Khusainova R, Zakharova E, Bychkov I Front Endocrinol (Lausanne). 2025; 16:1525373.

PMID: 39944202 PMC: 11813780. DOI: 10.3389/fendo.2025.1525373.


The natural product rotundic acid treats both aging and obesity by inhibiting PTP1B.

Zhu J, An Y, Wang X, Huang L, Kong W, Gao M Life Med. 2025; 1(3):372-386.

PMID: 39872740 PMC: 11749463. DOI: 10.1093/lifemedi/lnac044.


Multi Targeted Activity of Cocculus hirsutus through Modulation of DPP-IV and PTP-1B Leading to Enhancement of Glucose Uptake and Attenuation of Lipid Accumulation.

Bhuvaneswari D, Riitvek B, Lakshmi B Appl Biochem Biotechnol. 2025; .

PMID: 39760988 DOI: 10.1007/s12010-024-05142-8.


The Mechanism of Leptin Resistance in Obesity and Therapeutic Perspective.

Engin A Adv Exp Med Biol. 2024; 1460:463-487.

PMID: 39287862 DOI: 10.1007/978-3-031-63657-8_16.


Protein tyrosine phosphatase 1B in metabolic and cardiovascular diseases: from mechanisms to therapeutics.

Sun Y, Dinenno F, Tang P, Kontaridis M Front Cardiovasc Med. 2024; 11:1445739.

PMID: 39238503 PMC: 11374623. DOI: 10.3389/fcvm.2024.1445739.


References
1.
Faure R, Baquiran G, Bergeron J, Posner B . The dephosphorylation of insulin and epidermal growth factor receptors. Role of endosome-associated phosphotyrosine phosphatase(s). J Biol Chem. 1992; 267(16):11215-21. View

2.
Silva J, Rabelo R . Regulation of the uncoupling protein gene expression. Eur J Endocrinol. 1997; 136(3):251-64. DOI: 10.1530/eje.0.1360251. View

3.
Ahmad F, Li P, Meyerovitch J, Goldstein B . Osmotic loading of neutralizing antibodies demonstrates a role for protein-tyrosine phosphatase 1B in negative regulation of the insulin action pathway. J Biol Chem. 1995; 270(35):20503-8. DOI: 10.1074/jbc.270.35.20503. View

4.
Tozzo E, Gnudi L, Kahn B . Amelioration of insulin resistance in streptozotocin diabetic mice by transgenic overexpression of GLUT4 driven by an adipose-specific promoter. Endocrinology. 1997; 138(4):1604-11. DOI: 10.1210/endo.138.4.5043. View

5.
Di Guglielmo G, Drake P, Baass P, Authier F, Posner B, Bergeron J . Insulin receptor internalization and signalling. Mol Cell Biochem. 1998; 182(1-2):59-63. View